Anthony A. McKinney,Gary D. Tollefson,Richard Soltero,Thea Elise Dunzo
申请号：
US14826086
公开号：
US20160158221A1
申请日:
2015.08.13
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.
